Skip to main content
. 2018 Jul 17;9(55):30513–30526. doi: 10.18632/oncotarget.25495

Figure 4. Breast cancer–specific survival (BCSS) according to APOBEC3B mRNA expression among the different subtypes.

Figure 4

Kaplan-Meier plots showing the association of APOBEC3B mRNA expression with BCSS. (A) ER+ cases, (B) ER- cases, (C) HER2+ cases, (D) HER2- cases, (E) Luminal (ER+ and/or PgR+, HER2-) cases, (F) Luminal-HER2 (ER+ and/or PgR+, HER2+), (G) HER2-enriched (ER- and PgR-, HER2+), (H) triple-negative (ER-, PgR- and HER2-) cases.